Prolia (Denosumab) Maintains Menopausal Women's Bone Density For Over Eight Years
Links shared publicly online about this topic.
- 0total visits
Prolia (Denosumab) Maintains Menopausal Women's Bone Density For Over Eight Years
Postmenopausal females with osteoporosis or low bone mass who are on Prolia (denosumab) treatment were found to have continued increase in BMD (bone mineral density) for up to eight years, Amgen a
View full resource at medicalnewstoday.com
Tags: Menopause, Bone, Osteoporosis, Osteoporosis Medication, Women's Health, Prolia
Most Recently Shared on September 19, 2011 at 7:46 pm By:
Prolia (Denosumab) Maintains Menopausal Women's Bone Density For Over Eight Years http://t.co/u8BFtVbt via @mnt_menopause #health #medicine
Also Shared By:
Advertisement
MNT Menopause
@mnt_menopause
Prolia (Denosumab) Maintains Menopausal Women's Bone Density For Over Eight Years http://mnt.to/3ZJM #menopause
1 year ago...